Cardlytics Q1 2025 10-Q Filed
Ticker: CDLX · Form: 10-Q · Filed: May 7, 2025 · CIK: 1666071
| Field | Detail |
|---|---|
| Company | Cardlytics, Inc. (CDLX) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, equity
TL;DR
Cardlytics Q1 10-Q is in. Financials updated, check retained earnings.
AI Summary
Cardlytics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including changes in common stock, additional paid-in capital, accumulated other comprehensive income, and retained earnings. Specific dollar amounts and dates related to these financial statement line items are provided within the report.
Why It Matters
This filing provides investors with the latest financial performance and position of Cardlytics, Inc. for the first quarter of 2025, crucial for understanding the company's ongoing operations and financial health.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new risks disclosed.
Key Numbers
- 2025 Q1 — Reporting Period (First quarter of 2025 financial data)
- 2025-03-31 — As of Date (End of the reporting period for balance sheet items)
Key Players & Entities
- Cardlytics, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250507 (date) — Filing date
FAQ
What were the key changes in Cardlytics' equity accounts during the first quarter of 2025?
The filing indicates changes in Common Stock, Additional Paid-In Capital, Accumulated Other Comprehensive Income, and Retained Earnings for the period from January 1, 2025, to March 31, 2025.
What is the fiscal year end for Cardlytics, Inc.?
Cardlytics, Inc.'s fiscal year ends on December 31.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on May 7, 2025.
What is the SEC file number for Cardlytics, Inc.?
The SEC file number for Cardlytics, Inc. is 001-38386.
What is the business address of Cardlytics, Inc.?
The business address is 675 Ponce de Leon Avenue, NE, Suite 4100, Atlanta, GA 30308.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Cardlytics, Inc. (CDLX).